Skip to content
DraconiticResearch
Search Sources API
211,646 studies31 sourcesUpdated just now

Oncology

5,331 studies510 in 7 days2,567 in 30 days

Filters
Type
Date
Clear

Latest

5,331 studies

  1. Spectrum and immunovirological determinants of tumours among people living with HIV in Uganda: A retrospective cross sectional study from a specialised HIV centre, 2017–2026
    Joseph Mwaka, Conrad Sserunjogi, Jesca Natalayi
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  2. In-silico personalized protein–protein interaction networks prioritize candidate compounds for glioblastoma
    Nicoleta Siminea, Victor-Bogdan Popescu, Mihaela Păun +2
    PLOS Computational BiologyPeer-reviewedCC BY 4.0Full textOncologyPLOS
  3. Protocol of the PANEM trial: A randomized, phase III, parallel-arm, placebo-controlled, double-blind, multi-center superiority trial comparing PANcreatic EnzyMes versus placebo in adults after gastrectomy
    Kevin Thomas, Charlotte Ackmann, Anett Schmiedeknecht +16
    PLOS OnePeer-reviewedCC BY 4.0Full textNutritionOncologyPhysiologyPLOS
  4. A recurrent cancer-associated fibroblast/TGF-beta/endothelial barrier direction is associated with immune exclusion and checkpoint resistance in bladder cancer: a public multi-cohort transcriptomic study
    Yuye Wu, Guangjie Li, Lixing Jiang +3
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  5. Treatment-Free Interval as a Prognostic Factor for Survival Outcomes in Patients with Advanced or Recurrent Endometrial Cancer Treated with Pembrolizumab Plus Lenvatinib: A Multi-Institutional Real-World Cohort Study
    Chih-Wen Su, Shao-Jing Wang, Yu-Hsiang Shih +9
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  6. Tarlatamab in Small Cell Lung Cancer and Extrapulmonary Small Cell Carcinoma: A Single-Centre Retrospective Cohort Study of Routine-Practice Outcomes
    Ayrton Bangolo, Lili Zhang, Jiahe Zhao +37
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  7. Urine Drug Testing at an Ambulatory Pain Clinic in Patients Receiving Opioids for Cancer Pain †
    Jaya Amaram-Davila, Varsha Pawate, Sriram Yennurajalingam +11
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  8. Re-Evaluating Multi-Kinase Inhibitors Targeting FGFR and VEGFR Pathways for Combined Therapy in Colorectal Cancer: A Preclinical Study
    Sergei Boichuk, Tatyana Gessel, Pavel Dunaev +5
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  9. Vietnamese expert consensus on the diagnosis and multidisciplinary management of resectable non-small cell lung cancer
    Que Kim Do, Dung Xuan Pham, Hoa Thi Thai Nguyen +9
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  10. Multi-Scale MRI, Radiology Reports, and Blood Biomarker–Guided Multimodal Deep Learning for Predicting Postoperative Recurrence in Cervical Cancer: A Multicenter Study
    Yiyang Wu, Yao Ai, Yangyang Zhang +8
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  11. Plain language summary of the RELATIVITY-098 study results: nivolumab plus relatlimab given after melanoma is removed by surgery
    Georgina Long, Charlie Garnett-Benson, Sonia Dolfi +23
    Future OncologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyHAL
  12. Beyond Phenylbutyric Acid: Evans Blue and Ibuprofen as Albumin- Binding Motifs for PSMA-Targeted Radioligand Therapy of Prostate Cancer
    Cyril Fersing, Johanne Vanney, Jade Torchio +2
    Current Topics in Medicinal ChemistryPeer-reviewedCC BY 4.0Full text1 citedMedical imaging & radiologyOncologyHAL
  13. The impact of surgical excision modalities of Merkel cell carcinoma of the head and neck on recurrence, survival, and quality of life: A systematic review
    M. Geoffroy, F. Alibert, M. Fadel +2
    European Annals of Otorhinolaryngology, Head and Neck DiseasesPeer-reviewedCC BY 4.0Full textOncologyHAL
  14. Decoding the role of cancer-associated fibroblasts in cisplatin resistance of head and neck squamous cell carcinoma
    Dongmei Liu, Dilong Yu, Mengyu Chen +5
    iSciencePeer-reviewedCC BYFull textOncologyCell PressEurope PMC
  15. Precision de-escalation in HER2-enriched breast cancer: promise and pitfalls of multiomic response predictors
    Jessé Lopes da Silva, Andréia Cristina de Melo
    Translational Breast Cancer ResearchPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  16. Clinicopathologic and molecular features of head and neck NUT carcinoma: Analysis of 25 cases, including 5 with adenoid differentiation
    Yunyun Yang, Yue Hao, Chunwei Xu +4
    Therapeutic Advances in Medical OncologyPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  17. Association of Clinicopathological Features With Locoregional Recurrence and Disease Outcomes Among Female Breast Cancer Patients at Tikur Anbessa Specialized Hospital, Ethiopia: A Hospital-Based Retrospective Cohort Study
    Hidaya Yahya Mohammed, Isa Salo Abdo, Yonas Girma Shumiye +1
    Cancer Control: Journal of the Moffitt Cancer CenterPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  18. A low-matrix organoid-T cell co-culture platform for functional evaluation of T cell engagers in patient-derived colorectal cancer organoids
    C. M. A. PINNA, K. Rakhimova, J. Zhang +13
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  19. MYC-Hyperactivated Osteosarcoma Models Exhibit Resistance to Cabozantinib plus TIGIT Blockade
    S. S. Kappa, T. Patel, B. Nirala +3
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  20. β3-Integrin controls pericyte metabolic states and shapes tumour-stromal metabolic crosstalk in breast cancer
    E. Heylen, A. Jordan, K. Baird +9
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  21. Stromal innervation is prognostic in non-muscle-invasive bladder cancer and predicted by a distinct microenvironmental transcriptomic signature
    C. S. Deiter, C. de Jong, M. Olislagers +3
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  22. Loss of TCA cycle turning promotes stem cell function
    Y. Li, J. Rose, E. O. Kwarteng +6
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  23. DNMT1-Mediated Epigenetic Reprogramming Drives KMT2A Amplifications and Rearrangements
    M. A. Lineberger, Z. H. Gray, B. I. Ferman +28
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  24. Glucosylceramide synthase is required for C6-ceramide nanoliposome-induced organelle stress and cell death
    L. R. Vass, E. W. Smith, J. M. Cavanaugh +6
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  25. FFPE-CUTAC: A Single Assay, Multiple Layers
    Y. Niu, Q. Xu, C. Y. Mak +9
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv